How To: Endoscope-Assisted Transoral Procedure of Accessory Parotid Gland Tumor Resection

INTRODUCTION

The accessory parotid gland (APG) is a salivary tissue anatomically separated from the main parotid gland, located between the skin and the masseter muscle, with a reported prevalence of 32%. Tumors arising from APG account for 1 ~ 7.7% of all parotid tumors, existing with a higher frequency of benign lesions. Among APG tumors, pleomorphic adenoma (PA) is the most common benign type, followed by mucoepidermoid carcinoma (MEC) as the most common malignancy. Although relatively rare, an APG tumor should be considered when a non-tender mass is detected in the mid-cheek region.

Surgical resection is the recommended first choice of treatment for APG tumors. Accessing the APG region through conventional Blair or facelift incisions can be challenging, requiring extensive flap elevation and longer operation duration. The cheek incision is also recommended and thought easy to perform, but it leaves a visible external scar. Compared with the direct transcutaneous incision, the transoral approach has been increasingly carried out in recent years, with better post-operative cosmetic effects. Furthermore, advancements in endoscopic instruments and techniques have provided a promising alternative for the resection of APG tumors, mitigating the injury to anterior facial nerve branches and Stensen’s duct (SD) due to enhanced visualization.

MATERIALS AND METHODS

The selected case was a 30-year-old male with a chief complaint of a painless, slowly growing mass in the left cheek for three months. Pre-operative ultrasonography and contrast-enhanced computed tomography (CT) identified a well-circumscribed mass measuring 2.5 × 1.9 cm within the APG region, adjacent to the surface of the masseter muscle (Fig. 1A). Fine-needle aspiration cytology (FNAC) did not provide a definitive diagnosis. With the desire to avoid an external obvious scar, the patient opted for the endoscope-assisted transoral approach we proposed. The patient was thoroughly informed about the advantages and disadvantages of this procedure, as well as the potential for conversion to a standard conventional approach if necessary. Given the involvement of the intra-oral incision, it was advisable to conduct thorough dental prophylaxis pre-operatively to reduce the risk of infection. Post-operative cosmetic outcomes and patient satisfaction were evaluated six months after surgery using a visual analog scale (VAS), ranging from 0 (very dissatisfied) to 10 (no visible scar and very satisfied). The operation was conducted according to the Declaration of Helsinki (as revised in 2013).

Surgical Technique

Under general anesthesia and nasotracheal intubation, the patient was placed in a supine position with the shoulders raised by a surgical drape. The opening of the SD was clearly identified (Fig. 1B) under the magnification and illumination of an endoscope (5 mm, 0-degree rigid scope, STORZ, Germany). Based on the anticipated location of the APG tumor on the pre-operative contrast-enhanced CT, an approximately 4-cm transoral incision was made anterior to the left pterygomandibular ligament over the mass. When incising the buccal mucosa, submucosa, and buccinator muscle layer by layer, a monopolar electrocautery could be used to manage bleeding. The mucosal flap and buccinator muscle were elevated together to ensure an adequate operative field. With further blunt dissection, the facial artery and facial vein were gradually exposed and preserved. Care should be taken to ascertain the location of the SD when separating the anterior border of the masseter muscle (Fig. 1C). The APG mass was revealed following the retraction of the buccinator muscle and the anterior masseter muscle, aligning with the SD (Fig. 1D).